Metformin inhibited the IL-1β-induced release of the proinflammatory cytokines IL-6 and IL-8 in vascular wall cells34 and endometriotic stromal cells35, explaining in part metformin’s benefits in cardiovascular and endometriosis disease treatment. Here, CXCL8 is linked to endometriosis.